Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
2,206,022
Value
$39.6M
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of SRPT by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,206,022$39.6M<0.1%+1,480,954+204.3%AddedHolders
Q1 2026725,068$15.8M<0.1%+581,575+405.3%AddedHolders
Q4 2025143,493$3.09M<0.1%+38,380+36.5%AddedHolders
Q3 2025105,113$2.03M<0.1%+105,113NewHolders
Q2 20250$00.0%−27,197−100.0%Sold outHolders
Q1 202527,197$1.74M<0.1%+27,197NewHolders
Q4 20240$00.0%−42,938−100.0%Sold outHolders
Q3 202442,938$5.36M<0.1%−397−0.9%ReducedHolders
Q2 202443,335$6.85M<0.1%+39,992+1,196.3%AddedHolders
Q1 20243,343$432.8K<0.1%+3,343NewHolders
Q4 20230$00.0%−245,928−100.0%Sold outHolders
Q3 2023245,928$29.8M0.1%+186,886+316.5%AddedHolders
Q2 202359,042$6.76M<0.1%−120,217−67.1%ReducedHolders
Q1 2023179,259$24.7M0.1%−6,746−3.6%ReducedHolders
Q4 2022186,005$24.1M0.1%+186,005NewHolders
Q1 20220$00.0%−503,638−100.0%Sold outHolders
Q4 2021503,638$45.4M0.1%+500,289+14,938.5%AddedHolders
Q3 20213,349$310.0K<0.1%−16,170−82.8%ReducedHolders
Q2 202119,519$1.52M<0.1%−3,617−15.6%ReducedHolders
Q1 202123,136$1.73M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.